CURRENT REPORT FOR ISSUERS SUBJECT TO THE 1934 ACT
REPORTING REQUIREMENTS
FORM 8-K/A
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
August 11, 2006
Date of Report
(Date of Earliest Event Reported)
Commission File No. 0-29935
Micro Bio-Medical Waste Systems, Inc.
(Exact name of Registrant as specified in its charter)
Nevada, USA 33-0677140
(State of Incorporation) (IRS Employer Identification No.)
27430 Riverside Lane, Valencia, CA 91354
(Address of principal executive offices)(Zip Code)
Company's telephone number, including area code: (661) 287-3772
ITEM 4.01 CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT
LBB & Associates, Ltd., LLP. (LBB) was dismissed on August 11, 2006 as our
independent auditors. LBB's reports dated March 28, 2006 and April 25, 2005 on
our balance sheets of Micro Bio-Medical Waste Systems, Inc. as of December 31,
2005 and December 31, 2004, respectively, and the related statements of
operations, stockholders' equity, and cash flows for each of the two years then
ended, did not contain an adverse opinion or disclaimer of opinion, or
qualification or modification as to uncertainty, audit scope, or accounting
principles. However, both reports contained an explanatory paragraph disclosing
the uncertainty regarding the ability of the Company to continue as a going
concern.
During the two most recent fiscal years ended December 31, 2005 and 2004, and in
the subsequent interim period, there were no disagreements with LBB on any
matters of accounting principles or practices, financial statement disclosure,
or auditing scope and procedures which, if not resolved to their satisfaction
would have caused them to make reference to the matter in their report. We have
requested them to furnish a letter addressed to the Commission stating whether
it agrees with the above statements. A copy of the LBB letter is filed as
Exhibit 16.1 to this amended Form 8-K. Malone & Bailey, PC (M&B) was engaged on
August 11, 2006 as our principal accountant. The decision to change accountants
was approved by the Board of Directors.
The managing shareholder of LBB used to work with M&B until July 5, 2004, and
M&B was our auditors for 2003 and prior years. During 2004 and 2005, and through
the date hereof, and except for the situation noted above, neither we nor anyone
on our behalf consulted with M&B regarding either the application of accounting
principles to a specified transaction, either completed or proposed, or the type
of audit opinion that might be rendered on our financial statements, nor has M&B
provided to us a written report or oral advice regarding such principles or
audit opinion or any matter that was the subject of a disagreement or reportable
events set forth in Item 304(a)(iv) and (v), respectively, of Regulation S-K
with LBB.
We have requested M&B review the disclosure in this report on Form 8-K and
provided M&B the opportunity to furnish us with a letter addressed to the
Commission containing any new information, clarification of our expression of
our views, or the respects in which M&B does not agree with the statements made
by us in this report. M&B has advised us that no such letter need be issued.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(a) Not applicable
(b) Not applicable
(c) Exhibit No. Description (see below):
EXHIBIT DESCRIPTION LOCATION
------- ----------- --------
16.1 Letter sent to SEC from LBB & Associates, Ltd., Provided
LLP dated August 24, 2006 herewith
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Current Report on Form 8-K to be signed on its
behalf by the undersigned hereunto duly authorized.
Micro Bio-Medical Waste Systems, Inc.
By: /s/ Charles Smith
---------------------------
Name Charles Smith
Chief Executive Office
Dated: August 24, 2006